Information about activity of enamel demineralization has not been available previously and enables the preventive dentistry approach.
By supporting early decision making and improving patient communication, compliance with oral health advice increases and consent for prescribed treatment improves leading to enhanced clinical and professional outcomes.²
CALCIVIS® was co-founded in 2012 by Adam Christie (CEO) and Bruce Vernon (CTO). From its headquarters in Edinburgh, the CALCIVIS® team combines product development, clinical and commercial expertise. The CALCIVIS® Imaging System was developed with input from leading International specialists in caries and erosion.
Since then multiple preclinical and clinical studies have been undertaken including one pivotal clinical study designed to support our regulatory filing to the FDA leading to it’s approval.
Additionally, the CALCIVIS® Imaging System has the UKCA mark for the UK.
CALCIVIS® is internationally focused and actively forming relationships with leading clinicians and other stakeholders in dental markets around the world.